Evaluation of Right Ventricular Function Post Mitral Valve Operations in Patients With Pulmonary Hypertension.

Assiut University0 sites50 target enrollmentMarch 1, 2023

ConditionsRight Ventricular Dysfunction

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Right Ventricular Dysfunction
Sponsor: Assiut University
Enrollment: 50
Primary Endpoint: Right Ventricular function post mitral valve surgeries in patients with pulmonary hypertension
Status: Not yet recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

We aim to determine the function of Right ventricle post mitral valve surgeries in patients with pulmonary hypertension using transthoracic echocardiography3- and 6-months post-operatively to detect the effect of mitral valve surgeries over the RV function whether improving, deteriorating, or not changing at all.

Registry

clinicaltrials.gov

Start Date

March 1, 2023

End Date

November 1, 2026

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Assiut University

Responsible Party

Principal Investigator

Mohammad Ali Mohammad Abdelbakey

Resident

Assiut University

Eligibility Criteria

Inclusion Criteria

•Patients who underwent mitral valve surgeries who also had pulmonary hypertension in the period between March 2019 and March 2022 in Assiut university heart hospital

Exclusion Criteria

•Patients who underwent mitral valve surgeries with normal pulmonary pressure. Patients who had other valve surgeries besides mitral as aortic and/or tricuspid valve surgeries. Patients had mitral valve surgeries with other heart conditions that needed another intervention in the same session as CABG for IHD.

Outcomes

Primary Outcomes

Right Ventricular function post mitral valve surgeries in patients with pulmonary hypertension

Time Frame: From March 2019 till March 2022

to detect right ventricular function (ejection fraction percentage and/or TAPSE) through transthoracic echocardiography 3- and 6-months post operatively in patients who had mitral valve surgeries with pulmonary hypertension.